Literature DB >> 73950

Absorption, hydroxylation, and excretion of vitamin D3 in primary biliary cirrhosis.

E L Krawitt, M J Grundman, E B Mawer.   

Abstract

Oral vitamin D3 was poorly absorbed by 4 out of 6 patients with primary biliary cirrhosis; absorption was negatively correlated with faecal fat excretion. 25-hydroxylation of vitamin D3 given by mouth or intravenously was not impaired in the patients compared with controls of similar vitamin-D nutritional status. Urinary radioactivity derived from the intravenous dose of vitamin D3 was significantly greater in patients than in controls and was positively correlated with the serum-bilirubin concentration. Excretion in the urine may lead to loss of administered and endogenous vitamin D and thus contribute to vitamin-D deficiency in patients with primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 73950     DOI: 10.1016/s0140-6736(77)92660-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

Review 1.  Osteoporosis across chronic liver disease.

Authors:  M Guarino; I Loperto; S Camera; V Cossiga; C Di Somma; A Colao; N Caporaso; F Morisco
Journal:  Osteoporos Int       Date:  2016-02-04       Impact factor: 4.507

Review 2.  Bone disease after liver transplantation.

Authors:  M S Losowsky; S H Hussaini
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

3.  27-Oxygenation of C27-sterols and 25-hydroxylation of vitamin D3 in kidney: cloning, structure and expression of pig kidney CYP27A.

Authors:  H Postlind; F Hosseinpour; M Norlin; K Wikvall
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

Review 4.  Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease.

Authors:  J E Compston
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

5.  Amount and composition of bone minerals in chronic liver disease.

Authors:  J A Kalef-Ezra; M H Merkouropoulos; A Challa; J Hatzikonstantinou; A H Karantanas; E V Tsianos
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

6.  Osteomalacia in chronic liver disease.

Authors:  J B Dibble; M S Losowsky
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-17

7.  Effect of oral 1,25 dihydroxycholecalciferol on calcium and phosphate malabsorption in primary biliary cirrhosis.

Authors:  K Farrington; O Epstein; Z Varghese; S P Newman; J F Moorhead; S Sherlock
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

8.  Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3.

Authors:  J E Compston; L W Horton; R P Thompson
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

9.  Vitamin D deficiency, osteomalacia, and primary biliary cirrhosis. Response to orally administered vitamin D3.

Authors:  M Davies; E B Mawer; H J Klass; G A Lumb; J L Berry; T W Warnes
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

10.  Comparative absorption of vitamin D3 and 25-hydroxyvitamin D3 in intestinal disease.

Authors:  M Davies; E B Mawer; E L Krawitt
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.